Cite
Martin AS, Abraham DM, Hershberger KA, et al. Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model. JCI Insight. 2017;2(14)doi: 10.1172/jci.insight.93885.
Martin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., Locasale, J. W., Payne, R. M., & Hirschey, M. D. (2017). Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model. JCI insight, 2(14), . https://doi.org/10.1172/jci.insight.93885
Martin, Angelical S, et al. "Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model." JCI insight vol. 2,14 (2017). doi: https://doi.org/10.1172/jci.insight.93885
Martin AS, Abraham DM, Hershberger KA, Bhatt DP, Mao L, Cui H, Liu J, Liu X, Muehlbauer MJ, Grimsrud PA, Locasale JW, Payne RM, Hirschey MD. Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy model. JCI Insight. 2017 Jul 20;2(14). doi: 10.1172/jci.insight.93885. eCollection 2017 Jul 20. PMID: 28724806; PMCID: PMC5518566.
Copy
Download .nbib